Status:
COMPLETED
The Contribution of Intrathecal Morphine Administration to Postoperative Patient Satisfaction During Cesarean Delivery
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Cesarean Section
Intrathecal Morphine
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Evaluating the contribution of intrathecal morphine administration to postoperative patient satisfaction during cesarean delivery with the QoR-40 (Quality of Recovery 40) patient satisfaction compilat...
Detailed Description
All patients, whose consent was obtained, were monitored for standard noninvasive blood pressure, heart rate (HR), electrocardiogram (ECG) findings, and peripheral oxygen saturation (SpO2) in the oper...
Eligibility Criteria
Inclusion
- Between 18-40 years old,
- ASA physical status 2
- Patients who will give birth by elective cesarean section
Exclusion
- Those who do not accept regional anesthesia,
- Pregnant women who have problems where spinal anesthesia is contraindicated, such as infection at the injection site, coagulopathy, bleeding diathesis, severe hypovolemia, increase in intracranial pressure, severe aortic stenosis, severe mitral stenosis,
- Patients with a history of allergy to any drug included in the study protocol
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06076018
Start Date
November 20 2023
End Date
April 30 2024
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayıs University Faculty of Medicine
Samsun, Turkey (Türkiye)